ReadLinks

Since 2012, a total of 181,800 kits have been reported as distributed by Take Home Naloxone (THN) sites in British Columbia (BC). Of those, more than 50,000 kits have been used to reverse an overdose.

Pharmacy care for residential care patients is essential to our health care system and the well-being of our aging population. As the senior population size, medical complexities and number of transitions between levels of care increase, so does the probability of medication incidents and the potential for ill effects.

As a relatively new component of the Practice Review Program, Compliance Officers would like to share some of their early findings in areas where non-compliance has been observed for residential care services. 

On December 16, 2019, new federal regulations, associated with the Protecting Canadians from Unsafe Drugs Act (also known as Vanessa’s Law), will come into effect requiring hospitals across the country to report serious adverse drug reactions (ADRs) and medical device incidents (MDIs) to Health Canada within 30 days of being documented within the hospital.

On November 5, 2019, the College received its Canada Award for Excellence – Silver Certification in the Excellence, Innovation and Wellness^® category.

Canadian Patient Safety Week runs from October 28 to November 1, 2019. Join the Canadian Patient Safety Institute in promoting best practices and inspiring improvement in patient safety and quality.